Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-27 @ 8:41 AM
Study NCT ID:
NCT04343404
Status:
COMPLETED
Last Update Posted:
2020-06-29
First Post:
2020-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Sponsor:
University Hospital, Strasbourg, France
Organization:
Study Overview
Official Title:
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECMO-COVID-19
Brief Summary:
Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: